Is Biocept, Inc. (BIOC) a Buy, Sell, or Hold?
NASDAQ : BIOC
Biocept, Inc.
$0.4349 USD
$0 (0.0%)
- Volume
- 572.52K
- Average Volume
- 2.16M
- Market Capitalization
- $450.79K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.49
- Year Low
- $0.43
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.97
Insider Activity Summary (Last 12 Months)
Insiders Buying
11
Insiders Selling
3
Amount of Insider Selling
$445
BIOC Insider Buying/Selling by Quarter
BIOC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Walsh Robert | officer: VP, Controller | 2023-06-16 | 30.9 | 2023-06-20 | |
| DAO-HADDOCK QUYEN THI | director | 2022-11-17 | A-Award | 0 | 2022-11-18 |
| DAO-HADDOCK QUYEN THI | None | 2022-11-17 | None | 2022-11-18 | |
| DAO-HADDOCK QUYEN THI | director: | 2022-11-17 | 0 | 2022-11-18 | |
| Chandler Marsha Alpert | director | 2022-07-08 | A-Award | 1.03 | 2022-09-08 |
| Chandler Marsha Alpert | director: | 2022-07-08 | A-Award | 0 | 2022-09-08 |
| Rubinstein Linda M | director: | 2022-07-08 | A-Award | 0 | 2022-09-08 |
| Gerhardt Bruce | director: | 2022-07-08 | A-Award | 0 | 2022-09-08 |
| ROYSTON IVOR | director | 2022-07-08 | A-Award | 1.03 | 2022-09-08 |
| ROYSTON IVOR | director: | 2022-07-08 | A-Award | 0 | 2022-09-08 |
| Wilson Margaret Faye | director: | 2022-07-08 | A-Award | 0 | 2022-09-08 |
| Taylor Darrell | officer: See remarks | 2022-03-31 | A-Award | 0 | 2022-04-04 |
| Marchand Philippe | officer: Chief Operations Officer | 2022-03-31 | A-Award | 0 | 2022-04-04 |
| Marchand Philippe | officer | 2022-03-08 | 0 | 2022-03-16 | |
| Taylor Darrell | officer: Sr. V.P., General Counsel | 2022-02-28 | A-Award | 2.39 | 2022-03-16 |
| Taylor Darrell | officer | 2022-02-14 | 0 | 2022-03-16 | |
| Riccitelli Samuel D | director, officer: Interim President and CEO | 2022-02-28 | A-Award | 2.39 | 2022-03-02 |
| Morales Antonino | director, officer: Interim CFO | 2022-02-28 | A-Award | 2.39 | 2022-03-02 |
| HALE DAVID F | director | 2021-12-09 | S-Sale | 4.0602 | 2021-12-10 |
| HALE DAVID F | director | 2021-12-09 | S-Sale | 4.0664 | 2021-12-10 |
| HALE DAVID F | director | 2021-12-09 | S-Sale | 4.0717 | 2021-12-10 |
| Nall Michael W. | officer: CEO & President | 2021-09-02 | A-Award | 0 | 2021-09-02 |
| Nall Michael W. | officer: CEO & President | 2021-09-02 | A-Award | 0 | 2021-09-02 |
| TERRY MICHAEL J | officer: Sr VP of Business Development | 2021-08-31 | A-Award | 3.62 | 2021-09-02 |
| DUGAN MICHAEL C | officer: Chief Med Off & Med. Director | 2021-08-31 | A-Award | 3.62 | 2021-09-02 |
| Kennedy Timothy | officer: CFO, COO & Secretary | 2021-08-31 | A-Award | 3.62 | 2021-09-02 |
| Wilson Margaret Faye | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Gerhardt Bruce | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| HALE DAVID F | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Chandler Marsha Alpert | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| ROYSTON IVOR | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Riccitelli Samuel D | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Rubinstein Linda M | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Morales Antonino | director | 2021-07-16 | A-Award | 3.77 | 2021-07-20 |
| Rubinstein Linda M | director | 2021-07-16 | 0 | 2021-07-20 | |
| Morales Antonino | director | 2021-07-16 | 0 | 2021-07-20 | |
| Riccitelli Samuel D | director | 2020-10-20 | A-Award | 4.63 | 2020-10-22 |
| Riccitelli Samuel D | director: | 2020-10-20 | 0 | 2020-10-22 | |
| TERRY MICHAEL J | officer: Sr VP Comm. Operations | 2020-10-01 | A-Award | 4.5 | 2020-10-05 |
| Kennedy Timothy | officer: CFO, Sr V.P. Operations & Sec. | 2020-10-01 | A-Award | 4.5 | 2020-10-05 |
| DUGAN MICHAEL C | officer: Chief Med Off & Med. Director | 2020-10-01 | A-Award | 4.5 | 2020-10-05 |
| Nall Michael W. | director, officer: CEO & President | 2020-10-01 | A-Award | 4.5 | 2020-10-05 |
| DUGAN MICHAEL C | officer: Chief Med Off & Med. Director | 2020-08-31 | A-Award | 0.665 | 2020-09-01 |
| DUGAN MICHAEL C | officer: Chief Med Off & Med. Director | 2020-08-18 | 0 | 2020-08-27 | |
| HALE DAVID F | director | 2020-06-12 | S-Sale | 0.5578 | 2020-06-12 |
| HALE DAVID F | director | 2020-06-12 | S-Sale | 0.555 | 2020-06-12 |
| HALE DAVID F | director | 2020-06-12 | S-Sale | 0.5545 | 2020-06-12 |
| Wilson Margaret Faye | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| Chandler Marsha Alpert | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| Gerhardt Bruce | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| HALE DAVID F | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| ROYSTON IVOR | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| HUEBNER BRUCE A | director | 2020-06-05 | A-Award | 0.4797 | 2020-06-09 |
| Dunn Cory | officer: Sr. VP Corp. Development | 2020-03-30 | 0.31 | 2020-04-22 | |
| Dunn Cory | officer: Sr. VP Corp. Development | 2020-03-30 | 0.91 | 2020-04-22 | |
| Dunn Cory | officer: Sr. VP Corp. Development | 2020-03-30 | 1.9 | 2020-04-22 | |
| Nall Michael W. | director, officer: CEO & President | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| HALE DAVID F | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| HALE DAVID F | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| ROYSTON IVOR | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| ROYSTON IVOR | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| Wilson Margaret Faye | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| Wilson Margaret Faye | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| Gerhardt Bruce | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| Gerhardt Bruce | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| Kennedy Timothy | officer: CFO, Sr V.P. Operations & Sec. | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| HUEBNER BRUCE A | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| HUEBNER BRUCE A | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| Chandler Marsha Alpert | director | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| Chandler Marsha Alpert | director | 2019-06-17 | A-Award | 1.02 | 2019-06-19 |
| ARNOLD LYLE J | officer: SR VP of R&D and CSO | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| Hendrick Edwin | officer: SVP, Chief Commercial Officer | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| TERRY MICHAEL J | officer: Sr VP Comm. Operations | 2019-04-30 | A-Award | 0.91 | 2019-06-19 |
| Hendrick Edwin | officer: SVP, Chief Commercial Officer | 2018-09-28 | A-Award | 2.75 | 2018-10-02 |
| Hendrick Edwin | officer | 2018-08-28 | 0 | 2018-09-07 | |
| Wilson Margaret Faye | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| ROYSTON IVOR | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| HUEBNER BRUCE A | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| Gerhardt Bruce | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| Chandler Marsha Alpert | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| HALE DAVID F | director | 2018-06-29 | A-Award | 0.2 | 2018-07-02 |
| Gerhardt Bruce | director | 2018-01-30 | P-Purchase | 0.45 | 2018-06-06 |
| Gerhardt Bruce | director | 2018-01-30 | P-Purchase | 0.5 | 2018-06-06 |
| Ally Bridge LB Healthcare Master Fund Ltd | 10 percent owner | 2017-08-09 | 0 | 2017-08-17 | |
| Ally Bridge LB Healthcare Master Fund Ltd | 10 percent owner | 2017-08-09 | 1.5 | 2017-08-17 | |
| Wilson Margaret Faye | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| ROYSTON IVOR | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Neff Edward A. | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| HUEBNER BRUCE A | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| HALE DAVID F | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Gerhardt Bruce | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Chandler Marsha Alpert | director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Singh Veena | officer: Sr VP & Sr Med Director | 2017-05-31 | A-Award | 0 | 2017-06-02 |
| Singh Veena | officer: Sr VP & Sr Med Director | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| ARNOLD LYLE J | officer: SR VP of R&D and CSO | 2017-05-31 | A-Award | 0 | 2017-06-02 |
| ARNOLD LYLE J | officer: SR VP of R&D and CSO | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Kennedy Timothy | officer: CFO, Sr V.P. Operations & Sec. | 2017-05-31 | A-Award | 0 | 2017-06-02 |
| Kennedy Timothy | officer: CFO, Sr V.P. Operations & Sec. | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Nall Michael W. | director, officer: CEO & President | 2017-05-31 | A-Award | 1.5 | 2017-06-02 |
| Nall Michael W. | director, officer: CEO & President | 2017-05-31 | A-Award | 0 | 2017-06-02 |